BioElectronics ActiPatch Drug Free Pain Therapy Receives United Kingdom National Health System Payment Coverage

FREDERICK, Md., Jan. 04, 2018 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com makes wearable, drug-free chronic pain therapy medical devices. It is pleased to announce that the UK’s government funded public health service, National Health System (NHS), has approved our application to cover and pay for ActiPatch® Musculoskeletal Pain Therapy. The NHS estimates that almost half … Continue Reading

BioElectronics Announces ActiPatch: Over-The-Counter Alternative to Opioids

FREDERICK, MD, Dec. 12, 2017 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced wearable consumer pain management medical device, ActiPatch, announced today the launch of ActiPatch for Over-The-Counter, drug-free pain relief as an alternative to Opioids. ActiPatch is approved by the FDA for Over-The-Counter sales for the adjunctive treatment of pain … Continue Reading

BioElectronics Announces the Launch of the ‘Try & Tell’ Program

FREDERICK, MD, Dec. 07, 2017 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced wearable consumer pain management medical device ActiPatch, announced today the launch of their “Try and Tell” program in the United States. The ActiPatch® Musculoskeletal Pain Therapy is a wearable medical device that is FDA cleared for non-prescription use. … Continue Reading

Andy Whelan, President BioElectronics Updates Uptick Newswire “Stock Day” Listeners

Phoenix, AZ , Nov. 20, 2017 (GLOBE NEWSWIRE) — Uptick Newswire announces interview by host Everett Jolly of returning guest Andy Whelan President of BioElectronics Corp. (OTC: BIEL, the “Company”). Starting off the interview, Mr. Whelan presented an overview of the Company’s pain products, its domestic and international sales, and clinical trials status. The interview … Continue Reading

BioElectronics Vietnam Distributor, PharmEvo, Announces Electroceutical Symposium, Expansion into Cambodia & The Maldives

FREDERICK, MD–(Marketwired – Nov 13, 2017) – BioElectronics Corporation (OTC PINK: BIEL) is the maker of advanced, non-prescription pain management medical devices. We are pleased to announce that PharmEvo, our distributor in Vietnam, is hosting an Electroceuticals symposium following a successful launch of their sales & marketing strategy. Additionally, PharmEvo is expanding their territory to cover … Continue Reading

BioElectronics to Showcase Products at World’s Largest Medical Tradeshow

FREDERICK, MD–(Marketwired – Nov 9, 2017) – BioElectronics Corporation (OTC PINK: BIEL) is the maker of advanced, non-prescription pain management medical devices. The company announced today that it will showcase its range of pain and inflammation reduction products at MEDICA 2017 in Germany, dubbed as the leading international tradeshow for the medical industry. The company will … Continue Reading

BioElectronics Corporation Announces US FDA OTC Clearances For Drug-free ActiPatch® Musculoskeletal Pain Therapy

FREDERICK, MD, USA, February 5, 2017 — BioElectronics Corporation (OTC Pink: BIEL), the maker of wearable pain therapy devices, announced today that it has received over-the-counter use market clearance from the US FDA for ActiPatch® for the adjunctive treatment of musculoskeletal pain related to (1) plantar fasciitis of the heel; and (2) osteoarthritis of the … Continue Reading